Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
Toshihiko Ishii, Takashi Ishida, Atae Utsunomiya, et al.
Clinical Cancer Research (2010) Vol. 16, Iss. 5, pp. 1520-1531
Closed Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
Takashi Ishida, Tatsuro Joh, Naokuni Uike, et al.
Journal of Clinical Oncology (2012) Vol. 30, Iss. 8, pp. 837-842
Open Access | Times Cited: 619
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim, M. Bagot, Lauren Pinter‐Brown, et al.
The Lancet Oncology (2018) Vol. 19, Iss. 9, pp. 1192-1204
Closed Access | Times Cited: 517
CCR4 and its ligands: from bench to bedside
Osamu Yoshie, Kouji Matsushima
International Immunology (2014) Vol. 27, Iss. 1, pp. 11-20
Open Access | Times Cited: 360
Biological functions of fucose in mammals
Michael Schneider, Esam Al-Shareffi, Robert S. Haltiwanger
Glycobiology (2017) Vol. 27, Iss. 7, pp. 601-618
Open Access | Times Cited: 355
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
Kenji Ishitsuka, Kazuo Tamura
The Lancet Oncology (2014) Vol. 15, Iss. 11, pp. e517-e526
Closed Access | Times Cited: 318
The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity
Natasha Ann Pereira, Kah Fai Chan, Pao Chun Lin, et al.
mAbs (2018) Vol. 10, Iss. 5, pp. 693-711
Open Access | Times Cited: 281
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Kevin O. Saunders
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 280
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy
Masao Matsuoka, K-T Jeang
Oncogene (2010) Vol. 30, Iss. 12, pp. 1379-1389
Open Access | Times Cited: 254
Pharmacological modulation of chemokine receptor function
Danny J. Scholten, Meritxell Canals, David Maussang, et al.
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1617-1643
Open Access | Times Cited: 243
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study
Takashi Ishida, Tatsuro Jo, Shigeki Takemoto, et al.
British Journal of Haematology (2015) Vol. 169, Iss. 5, pp. 672-682
Open Access | Times Cited: 236
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
Koji Kurose, Yoshihiro Ohue, Hisashi Wada, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 19, pp. 4327-4336
Open Access | Times Cited: 206
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
Catherine J. Hutchings, Markus Koglin, William C. Olson, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 11, pp. 787-810
Closed Access | Times Cited: 180
How to select IgG subclasses in developing anti-tumor therapeutic antibodies
Jifeng Yu, Yongping Song, Wenzhi Tian
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 178
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 34
Therapeutic antibodies directed at G protein-coupled receptors
Catherine J. Hutchings, Markus Koglin, Fiona H. Marshall
mAbs (2010) Vol. 2, Iss. 6, pp. 594-606
Open Access | Times Cited: 157
Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity
Sylvia Herter, Martina Birk, Christian Klein, et al.
The Journal of Immunology (2014) Vol. 192, Iss. 5, pp. 2252-2260
Open Access | Times Cited: 136
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002
Takashi Ishida, Hiroshi Fujiwara, Kisato Nosaka, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 34, pp. 4086-4093
Closed Access | Times Cited: 133
Stevens–Johnson Syndrome associated with mogamulizumab treatment of adult T‐cell leukemia / lymphoma
Takashi Ishida, Asahi Ito, Fumihiko Sato, et al.
Cancer Science (2013) Vol. 104, Iss. 5, pp. 647-650
Open Access | Times Cited: 124
The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity
Stefanie Scheu, Shafaqat Ali, Christina Ruland, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2306-2306
Open Access | Times Cited: 121
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
К.-С. Н. Атретханы, Marina S. Drutskaya, Sergei A. Nedospasov, et al.
Pharmacology & Therapeutics (2016) Vol. 168, pp. 98-112
Closed Access | Times Cited: 110
Peripheral T cell lymphomas: from the bench to the clinic
Danilo Fiore, Luca Vincenzo Cappelli, Alessandro Broccoli, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 6, pp. 323-342
Closed Access | Times Cited: 105
Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
Laura Chiossone, Margaux Vienne, Yann M. Kerdiles, et al.
Seminars in Immunology (2017) Vol. 31, pp. 55-63
Closed Access | Times Cited: 99
Recent advances in the treatment of adult T‐cell leukemia‐lymphomas
Atae Utsunomiya, Ilseung Choi, Dai Chihara, et al.
Cancer Science (2015) Vol. 106, Iss. 4, pp. 344-351
Open Access | Times Cited: 98
Mogamulizumab (Anti-CCR4) in HTLV-1–Associated Myelopathy
Tomoo Sato, Ariella Coler‐Reilly, Naoko Yagishita, et al.
New England Journal of Medicine (2018) Vol. 378, Iss. 6, pp. 529-538
Open Access | Times Cited: 96
Engineering therapeutic antibodies targeting G-protein–coupled receptors
Migyeong Jo, Sang Taek Jung
Experimental & Molecular Medicine (2016) Vol. 48, Iss. 2, pp. e207-e207
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top